Our support team is composed of knowledgeable professionals who are ready to assist you with any questions you may have
Unlike most peptides on the FDA's review schedule, GHK-Cu (copper peptide) has a split regulatory path: non-injectable routes are being removed from Category 1, while injectable routes are being removed from Category 2 and both are heading to Pharmacy Compounding Advisory Committee (PCAC) review before February 2027
Strategy 2: With a Meal (Containing Carbohydrates and Protein) Now, this is where the deeper science comes into play, and it's an approach we often favor for long-term, sustainable results
Reduced Glutathione, Vitamin C (Ascorbic Acid), Glycerin, Medium Chain Triglycerides, Phospholipids ( Soy (Soybeans) ), Natural Flavour For allergens, see ingredients in Bold